Insider Trading History of Cowell Richard

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Cowell Richard since 2009. The trader's CIK number is 1254951. At the time of the last reporting, Cowell Richard was the Director of Immunocellular Therapeutics, Ltd.. (stock ticker symbol IMUC). Also see all insider trading activities at Immunocellular Therapeutics, Ltd..

Note that in the past COWELL RICHARD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Microvision, Inc. (MVIS) by Cowell Richard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 MVIS 10,000 $9,040 0 $0 0 $0
2009 MVIS 3,500 $11,116 0 $0 0 $0

Yearly summary of insider trading at Immunocellular Therapeutics, Ltd. (IMUC) by Cowell Richard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 IMUC 0 $0 83,301 $288,333 83,301 $105,472


Insider trading activities at 2 companies by Cowell Richard:

1. Microvision, Inc. (MVIS)

2. Immunocellular Therapeutics, Ltd. (IMUC)

Table 1. Insider trading of Microvision, Inc. (MVIS) by Cowell Richard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-09-08 MVIS Buy 10,000 .90 9,040
2009-12-08 MVIS Buy 3,500 3.18 11,116

Table 2. Insider trading of Immunocellular Therapeutics, Ltd. (IMUC) by Cowell Richard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-11-26 IMUC Sale 28,000 3.86 108,052
2013-11-25 IMUC Sale 55,301 3.26 180,281
2013-11-26 IMUC Option Ex 28,000 1.15 32,199
2013-11-25 IMUC Option Ex 55,301 1.32 73,273

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cowell Richard (Director of Immunocellular Therapeutics, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.